Inflammatory Disease Marker Tests - Medical Devices Pipeline Assessment, 2020

Description Table of
Contents Companies Mentioned

FEATURED COMPANIES

Abcodia Ltd
BioSIMS
ELITechGroup Inc
LifeAssays AB
Quidel Corp
University Health Network
MORE

Summary

The publisher's Medical Devices sector report, “Inflammatory Disease Marker Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Inflammatory Disease Marker Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Inflammatory Disease Markers are antigen/antibodies that detect specific antigen/antibodies produced by bone, cartilage or any other inflammatory disease activity. This segment includes sub segment analyzer based tests and latex agglutination based tests.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Inflammatory Disease Marker Tests under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Inflammatory Disease Marker Tests and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment/industry

Reasons to Buy

The report enables you to -

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of Inflammatory Disease Marker Tests under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date

Note: Product cover images may vary from those shown

FEATURED COMPANIES

Abcodia Ltd
BioSIMS
ELITechGroup Inc
LifeAssays AB
Quidel Corp
University Health Network
MORE

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 Inflammatory Disease Marker Tests Overview

3 Products under Development

3.1 Inflammatory Disease Markers - Pipeline Products by Stage of Development
3.2 Inflammatory Disease Markers - Pipeline Products by Segment
3.3 Inflammatory Disease Markers - Pipeline Products by Territory
3.4 Inflammatory Disease Markers - Pipeline Products by Regulatory Path
3.5 Inflammatory Disease Markers - Pipeline Products by Estimated Approval Date

4 Inflammatory Disease Markers - Pipeline Products under Development by Companies

4.1 Inflammatory Disease Markers Companies - Pipeline Products by Stage of Development
4.2 Inflammatory Disease Markers - Pipeline Products by Stage of Development

5 Inflammatory Disease Markers Companies and Product Overview6 Inflammatory Disease Markers- Recent Developments

7 Appendix

7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer

List of Tables

Table 1: Inflammatory Disease Markers - Pipeline Products by Stage of Development
Table 2: Inflammatory Disease Markers - Pipeline Products by Segment
Table 3: Inflammatory Disease Markers - Pipeline Products by Territory
Table 4: Inflammatory Disease Markers - Pipeline Products by Regulatory Path
Table 5: Inflammatory Disease Markers - Pipeline Products by Estimated Approval Date
Table 6: Inflammatory Disease Markers Companies - Pipeline Products by Stage of Development
Table 7: Inflammatory Disease Markers - Pipeline Products by Stage of Development
Table 8: Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Molecular Biomarker - Rheumatoid Arthritis - Product Status
Table 10: Molecular Biomarker - Rheumatoid Arthritis - Product Description
Table 11: Adaltis Srl Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Hemo One - hs - CRP Assay - Product Status
Table 13: Hemo One - hs - CRP Assay - Product Description
Table 14: Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Diagnostic Kit - Rheumatoid Arthritis - Product Status
Table 16: Diagnostic Kit - Rheumatoid Arthritis - Product Description
Table 17: AnaMar AB Pipeline Products & Ongoing Clinical Trials Overview
Table 18: NeoSix Biomarker Assay - Product Status
Table 19: NeoSix Biomarker Assay - Product Description
Table 20: Arizona State University Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Diagnostic Test - Rheumatoid Arthritis - Product Status
Table 22: Diagnostic Test - Rheumatoid Arthritis - Product Description
Table 23: AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Multiplexed Detection - CRP - Product Status
Table 25: Multiplexed Detection - CRP - Product Description
Table 26: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: AU480 Clinical System - anti-CCP Assay - Product Status
Table 28: AU480 Clinical System - anti-CCP Assay - Product Description
Table 29: AU5810 Clinical System - anti-CCP Assay - Product Status
Table 30: AU5810 Clinical System - anti-CCP Assay - Product Description
Table 31: AU5820 Clinical System - anti-CCP Assay - Product Status
Table 32: AU5820 Clinical System - anti-CCP Assay - Product Description
Table 33: AU5830 Clinical System - anti-CCP Assay - Product Status
Table 34: AU5830 Clinical System - anti-CCP Assay - Product Description
Table 35: AU5840 Clinical System - anti-CCP Assay - Product Status
Table 36: AU5840 Clinical System - anti-CCP Assay - Product Description
Table 37: AU680 Clinical System - anti-CCP Assay - Product Status
Table 38: AU680 Clinical System - anti-CCP Assay - Product Description
Table 39: Multisystem Inflammatory Syndrome Diagnostic Test - Product Status
Table 40: Multisystem Inflammatory Syndrome Diagnostic Test - Product Description
Table 41: UniCel DxC 600 - anti-CCP Assay - Product Status
Table 42: UniCel DxC 600 - anti-CCP Assay - Product Description
Table 43: UniCel DxC 600i Synchron Access - anti-CCP Assay - Product Status
Table 44: UniCel DxC 600i Synchron Access - anti-CCP Assay - Product Description
Table 45: UniCel DxC 680i Synchron Access Clinical System - anti-CCP Assay - Product Status
Table 46: UniCel DxC 680i Synchron Access Clinical System - anti-CCP Assay - Product Description
Table 47: UniCel DxC 800 - anti-CCP Assay - Product Status
Table 48: UniCel DxC 800 - anti-CCP Assay - Product Description
Table 49: UniCel DxC 860i Synchron Access Clinical System - anti-CCP Assay - Product Status
Table 50: UniCel DxC 860i Synchron Access Clinical System - anti-CCP Assay - Product Description
Table 51: UniCel DxC 880i Synchron Access Clinical System - anti-CCP Assay - Product Status
Table 52: UniCel DxC 880i Synchron Access Clinical System - anti-CCP Assay - Product Description
Table 53: BIOHOPE Scientific SL Pipeline Products & Ongoing Clinical Trials Overview
Table 54: Inmunobiogram - Arthritis - Product Status

List of Figures

Figure 1: Inflammatory Disease Markers - Pipeline Products by Stage of Development
Figure 2: Inflammatory Disease Markers - Pipeline Products by Segment
Figure 3: Inflammatory Disease Markers - Pipeline Products by Territory
Figure 4: Inflammatory Disease Markers - Pipeline Products by Regulatory Path
Figure 5: Inflammatory Disease Markers - Pipeline Products by Estimated Approval Date

Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

Abcodia Ltd
Adaltis Srl
Albert Ludwigs University of Freiburg
AnaMar AB
Arizona State University
AXO Science SAS
Beckman Coulter Inc
BIOHOPE Scientific SL
BiomX Inc
BioSIMS
Boditech Med Inc
CD Diagnostics Inc
CDI Laboratories Inc
Chronix Biomedical Inc
Cincinnati Children's Hospital Medical Center
Consejo Superior de Investigaciones Cientificas
Crescendo Bioscience Inc
DSX Therapeutics LLC
DxTerity Diagnostics Inc
EKF Diagnostics Holdings Plc
ELITechGroup Inc
Firalis SAS
French National Institute of Health and Medical Research
Genalyte Inc
Ghent University
Helmholtz Zentrum Munchen Deutsches Forschungszentrum fur Gesundheit und Umwelt (GmbH)
Ignyta Inc
Johns Hopkins University
KineMed Inc
Leadgene Biomedical Inc
LifeAssays AB
Medica Corp
Merck Millipore Corp
Morehouse School of Medicine
Myriad Genetics Inc
Neoteryx LLC
Ortho-Clinical Diagnostics Inc
Phagolum Ltd.
Proplex Technologies Llc
Protagen AG
Queen Mary University of London
Quidel Corp
Roche Diagnostics Corp
Selventa Inc
Siemens Healthcare Diagnostics Inc
SomaLogic Inc
SpinChip Diagnostics AS
SQI Diagnostics Inc
StageZero Life Sciences Ltd
Svar Life Science AB
The University of Manchester
The Walter and Eliza Hall Institute of Medical Research
Thermo Fisher Scientific Inc
Toscana Biomarkers Srl
University Health Network
University of Aberdeen
University of Auckland
University of California
University of California Los Angeles
University of Gottingen
University of Oxford
University of Rochester
University of Warwick
University Rovira i Virgili

Note: Product cover images may vary from those shown

FEATURED COMPANIES

FEATURED COMPANIES

RELATED TAGS

RELATED PRODUCTS

AXL kinase inhibitors - Pipeline Insights, 2022

Inflammatory Disease Marker Tests - Medical Devices Pipeline Product Landscape, 2021

Specific Proteins Tests - Medical Devices Pipeline Product Landscape, 2021

Interleukin 6 inhibitors - Pipeline Insight, 2022

Biomarkers - Technologies, Markets & Companies